University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Red Oxandrolone 2.5mg tablets

Burns use only

Status: Green Oxybutynin immediate release tablets

For hyperhydrosis (off label use) after trial of alumnium salts

Status: Amber Oxybutynin patch (Kentera)

If first line is not tolerated, following specialist advice

Status: Amber Oxycodone hydrochloride capsules

Lynlor capsules preferred brand

Status: Amber Oxycodone hydrochloride M/R tablets

Reltebon MR tablets preferred brand

Status: Green Oxygen

Short term use in palliative care

Status: Amber Oxygen

Long term use - requires specialist assessment

Status: Red Paclitaxel injection

Negative TA

Status: Red Palifermin injection

Private patients only

Status: Red Paliperidone (Byannli®)

6 monthly injection

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top